(Q38023546)

27 August 2017

title

Role of CD44 in tumour progression and strategies for targeting (English)

1 reference

27 August 2017

1 reference

0 references

Lalit Mohan Negi

1

1 reference

27 August 2017

Sushama Talegaonkar

2

1 reference

27 August 2017

Manu Jaggi

3

1 reference

27 August 2017

Farhan J Ahmad

4

1 reference

27 August 2017

Zeenat Iqbal

5

1 reference

27 August 2017

Roop K Khar

6

1 reference

27 August 2017

publication date

1 August 2012

1 reference

Journal of Drug Targeting

27 August 2017

published in

1 reference

27 August 2017

volume

20

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

561-573

1 reference

Lateral interactions among membrane proteins. Implications for the organization of gap junctions

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Intratumoral delivery of Paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronic acid-quantum dot conjugates for in vivo lymphatic vessel imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Heparan sulphate proteoglycans fine-tune mammalian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemothera

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Increased hyaluronate synthesis is required for fibroblast detachment and mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Complete characterization of the human ABC gene family.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Decreasing the metastatic potential in cancers--targeting the heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Inhibitory effect of 4-methylesculetin on hyaluronan synthesis slows the development of human pancreatic cancer in vitro and in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan oligomers-HPMA copolymer conjugates for targeting paclitaxel to CD44-overexpressing ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

In vivo real-time bioimaging of hyaluronic acid derivatives using quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

CD44-targeted microparticles for delivery of cisplatin to peritoneal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Macrophages regulate the angiogenic switch in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Inhibition of hyaluronan export attenuates cell migration and metastasis of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronic acid-bound letrozole nanoparticles restore sensitivity to letrozole-resistant xenograft tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

CD44: structure, function, and association with the malignant process.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronidase reduces human breast cancer xenografts in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

The normal structure and function of CD44 and its role in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan metabolism: a major paradox in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan enters keratinocytes by a novel endocytic route for catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

A novel ligand for CD44 is sulfated proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Receptors for hyaluronate on the surface of parent and virus-transformed cell lines: binding and aggregation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Identification of hyaluronic acid-binding proteins and their expressions in porcine cumulus-oocyte complexes during in vitro maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Hyaluronan microspheres for sustained gene delivery and site-specific targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

Development of a hyaluronan bioconjugate for the topical treatment of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.702767

10.3109/1061186X.2012.702767

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference